- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
LGC Gives Update About Recent Medicinal Cannabis Investment
LGC Capital provided an update on its investment in Tricho-Med Corporation for shareholders.
LGC Capital (TSXV:LG) provided an update on itsĀ investment in Tricho-Med Corporation for shareholders.
As quoted in the press release:
AAA Trichomes is currently in the process of building its initial 34,000 square foot (Phase-1) Medical Cannabis production facility, located only twenty minutes south-west ofĀ MontrealāsĀ MirabelĀ International Airport.
The construction of the first stage of this new state-of-the-art greenhouse is now underway and is scheduled to be completed by the fall 2018.Ā AAA Trichomes is currently finalizing the selection of the turn-key contractors for the construction of the steel structure/outside envelope of the facility and is in the final process of choosing the Heating Venting and Air-Conditioning suppliers for the facility.Ā The company has already commenced detailed planning for its Phase-2 and Phase-3 expansions that will advance the facilityās overall size to over one million square feet of cultivating and processing capacity.
AAA Trichomes is on track for its Health Canada inspection by the fall of this year.Ā The company expects to run its two trial harvests as soon as Phase-1 construction is complete, which is a condition to being granted a full growing and production license.
Click here to read the full press release.
Source: www.newswire.ca
Investing News Network websites or approved third-party tools use cookies. Please refer to theĀ cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Ā